Latest On Corvus Pharmaceuticals, Inc (CRVS):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-12 22:21 EST | News | Corvus Pharmaceuticals: Targeting $1 Billion/Year U.S. T-Cell Lymphoma Market | N/A |  |
| 2023-05-08 22:39 EST | News | Corvus Pharmaceuticals GAAP EPS of -$0.17 misses by $0.01 | N/A | |
| 2023-05-08 22:39 EST | News | Corvus Pharmaceuticals, Inc. (CRVS) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-07 20:51 EST | News | Corvus Pharmaceuticals Q1 2023 Earnings Preview | N/A | |
| 2023-03-29 11:09 EST | News | Corvus Pharmaceuticals, Inc. (CRVS) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-28 20:35 EST | News | Corvus Pharmaceuticals GAAP EPS of -$0.21 beats by $0.02 | N/A | |
| 2022-11-07 01:12 EST | News | Corvus Pharmaceuticals, Inc. (CRVS) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-04 01:21 EST | News | Corvus Pharmaceuticals GAAP EPS of -$0.32 misses by $0.16 | N/A | |
| 2022-11-03 07:35 EST | News | Corvus Pharmaceuticals Q3 2022 Earnings Preview | N/A | |
| 2022-09-26 18:13 EST | News | Corvus' partner Angel Pharma gets nod to start phase 1/1b trial of cancer therapy in China | N/A | |
| 2022-08-09 00:57 EST | News | Corvus Pharmaceuticals GAAP EPS of -$0.18 in-line | N/A | |
| 2022-08-09 00:56 EST | News | Corvus Pharmaceuticals, Inc. (CRVS) CEO Richard Miller on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-06 08:07 EST | News | Corvus Pharmaceuticals Q2 2022 Earnings Preview | N/A | |
| 2022-05-06 01:39 EST | News | Corvus Pharmaceuticals GAAP EPS of -$0.18 | N/A | |
| 2022-03-11 09:34 EST | News | Corvus Pharmaceuticals GAAP EPS of -$0.20 misses by $0.01 | N/A | |
| 2022-03-11 09:34 EST | News | Corvus Pharmaceuticals, Inc. (CRVS) CEO Richard Miller on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-09 22:06 EST | News | Corvus Pharmaceuticals Q4 2021 Earnings Preview | N/A | |
| 2022-01-14 06:28 EST | News | Corvus Pharma initiates Phase 1/1b trial of CPI-818 for T-cell lymphomas in China | N/A | |
| 2021-12-11 08:34 EST | News | Checking In On Corvus Pharmaceuticals | N/A | |
| 2021-11-01 17:42 EST | News | Corvus Pharmaceuticals EPS misses by $0.03 | N/A | |
| 2021-09-24 02:10 EST | News | Corvus Pharmaceuticals: More Than A CD73 Sympathy Play | N/A | |
| 2021-09-23 00:42 EST | News | Corvus: Surging On AstraZeneca CD73 Success With Key Data Readout Looming | N/A | |
| 2021-09-21 15:24 EST | News | AstraZeneca lung cancer data propel Corvus and Arcus | N/A | |
| 2021-09-21 15:23 EST | News | CRVS, APRE, GDS and OYST among after hours movers | N/A | |
| 2021-09-21 15:23 EST | News | Corvus Pharma has stellar day closing 135% higher; reaches 52-week high after-hours | N/A | |
| 2021-09-21 15:20 EST | News | APRE, GMAB, VRCA and CRVS among after hours movers | N/A | |
| 2021-09-21 15:18 EST | News | Corvus Pharma extends gains to more than double in value this year | N/A | |
| 2021-08-17 11:34 EST | News | Corvus Pharma to commence Phase 1/1b trial of CPI-818 in China | N/A | |
| 2021-08-03 09:45 EST | News | Corvus Pharmaceuticals EPS in-line | N/A | |
| 2021-07-21 03:20 EST | News | Corvus Pharmaceuticals initiated buy at Cantor with a Street-high target | N/A | |
| 2021-07-21 02:29 EST | News | Corvus shares drop after scrapping late-stage mupadolimab COVID-19 trial | N/A | |
| 2021-07-21 02:28 EST | News | Corvus Pharma praised for its focus after end to COVID-19 study | N/A | |
| 2021-03-25 12:00 EST | News | Corvus Pharmaceuticals EPS beats by $1.16 | N/A | |
| 2021-03-12 22:57 EST | News | Corvus Pharmaceuticals (CRVS) Investor Presentation - Slideshow | N/A | |
| 2021-02-23 03:28 EST | Analyst Rating | The Analyst Target Price has increased from $8.6 to $9.25. | Buy | |
| 2021-02-20 01:27 EST | News | Corvus Pharma surges after an insider purchase of ~1.3M shares | N/A | |
| 2021-02-17 19:28 EST | News | Corvus closes 8.6M share public offering | N/A | |
| 2021-02-12 16:58 EST | News | Corvus shares slide after pricing 8.57M public offering | N/A | |
| 2021-02-11 23:25 EST | News | Corvus Pharma announces proposed public offering | N/A | |
| 2021-02-11 11:23 EST | Analyst Rating | The Analyst Target Price has decreased from $9.2 to $8.6. | Neutral | |
| 2021-02-11 05:12 EST | News | Corvus cut to neutral at Mizuho citing realignment of pipeline | N/A | |
| 2021-01-20 16:29 EST | News | Corvus Pharmaceuticals: Undervalued Based On COVID-19 Opportunity And Oncology Assets | N/A | |
| 2020-12-13 03:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-10 10:46 EST | News | Corvus' immunotherapy shows durable benefit in COVID-19 | N/A | |
| 2020-11-07 15:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 06:14 EST | News | Seeking Alpha Catalyst Watch | N/A | |
| 2020-11-02 17:03 EST | Analyst Rating | The Analyst Target Price has decreased from $9.6 to $9.2. | Neutral | |
| 2020-11-01 23:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-30 20:36 EST | Earnings Estimate | An EPS average of -$0.33 is estimated for the quarter ending on March 31, 2021. | N/A | |
| 2020-10-07 16:40 EST | Analyst Rating | The Analyst Target Price has increased from $9.2 to $9.6. | Buy | |
About Corvus Pharmaceuticals, Inc (CRVS):
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Ciforadenant (CPI-444), an oral, small molecule antagonist of the A2A receptor that is in Phase Ib/2 clinical trial for adenosine, an immune checkpoint. The company is also developing CPI-006, an anti-CD73 monoclonal antibody, which is in Phase I/Ib clinical trial that inhibits the production of adenosine and stimulate various immune cells, as well as Phase I clinical trial of CPI-006 for COVID-19; an antagonist of the adenosine A2B receptor; and CPI-818, a small molecule covalent inhibitor of interleukin-2-inducible T-cell kinase, that is Phase I/Ib clinical trial. Corvus Pharmaceuticals, Inc. also entered into a strategic collaboration with Angel Pharmaceuticals for the development its pipeline of targeted investigational medicines. The company was founded in 2014 and is based in Burlingame, California.
General
- Name Corvus Pharmaceuticals, Inc
- Symbol CRVS
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 52
- Fiscal Year EndDecember
- IPO Date2016-03-23
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.corvuspharma.com
View More
Valuation
- Price/Book (Most Recent Quarter) 2.95
- Enterprise Value EBITDA 0.14
View More
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$0.23
- Return on Assets -38%
- Return on Equity -72%
- Earnings Per Share -$1.56
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 120.35 million
- EBITDA -47441000
- Analyst Target Price $9.25
- Book Value Per Share $1.51
View More
Share Statistics
- Shares Outstanding 37.85 million
- Shares Float 17.12 million
- % Held by Insiders 498%
- % Held by Institutions 63.75%
- Shares Short 1.27 million
- Shares Short Prior Month 1.24 million
- Short Ratio 0.76
- Short % of Float 5%
- Short % of Shares Outstanding 3%
View More
Technicals
- Beta 1.77
- 52 Week High $5.28
- 52 Week Low $1.91
- 50 Day Moving Average 3.63
- 200 Day Moving Average 3.89
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Corvus Pharmaceuticals, Inc (CRVS) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Corvus Pharmaceuticals, Inc (CRVS) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-10-29 | $N/A | -$0.33 | -$0.22 | -51.72% |
| 2020-06-30 | 2020-07-30 | $N/A | -$0.36 | -$0.24 | -51.58% |
| 2020-03-31 | 2020-04-30 | $N/A | -$0.44 | -$0.41 | -8.64% |
| 2019-12-31 | 2020-03-05 | $N/A | -$0.38 | -$0.31 | -22.58% |
| 2019-09-30 | 2019-10-29 | $N/A | -$0.37 | -$0.43 | 13.29% |
| 2019-06-30 | 2019-08-01 | $N/A | -$0.44 | -$0.44 | -0.76% |
| 2019-03-31 | 2019-05-09 | $N/A | -$0.40 | -$0.48 | 16.05% |
| 2018-12-31 | 2019-03-07 | $N/A | -$0.36 | -$0.50 | 28% |
| 2018-09-30 | 2018-11-01 | $N/A | -$0.36 | -$0.49 | 26.03% |
| 2018-06-30 | 2018-08-02 | $N/A | -$0.40 | -$0.61 | 34.16% |
| 2018-03-31 | 2018-05-03 | $N/A | -$0.63 | -$0.77 | 18% |
| 2017-12-31 | 2018-03-01 | $N/A | -$0.58 | -$0.77 | 24.58% |
| 2017-09-30 | 2017-11-02 | $N/A | -$0.62 | -$0.84 | 25.82% |
| 2017-06-30 | 2017-08-03 | $N/A | -$0.73 | -$0.74 | 1.12% |
| 2017-03-31 | 2017-05-04 | $N/A | -$0.79 | -$0.77 | -2.6% |
| 2016-12-31 | 2017-03-10 | $N/A | -$0.55 | -$0.55 | -0.73% |
| 2016-09-30 | 2016-11-03 | $N/A | -$0.51 | -$0.45 | -13.33% |
| 2016-06-30 | 2016-08-04 | $N/A | -$0.43 | -$0.32 | -36.38% |
| 2016-03-31 | 2016-05-05 | $N/A | -$5.39 | -$6.09 | 11.49% |
Corvus Pharmaceuticals, Inc (CRVS) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Corvus Pharmaceuticals, Inc (CRVS) Chart:
Corvus Pharmaceuticals, Inc (CRVS) News:
Below you will find a list of latest news for Corvus Pharmaceuticals, Inc (CRVS) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Corvus Pharmaceuticals, Inc (CRVS) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-05-16 | 1 | 0 | CALL | 0 | 0 | 1444.09 | TRUE | 0 | 0 |
| 2025-05-16 | 2 | 2.1 | CALL | 9 | 90 | 464.52 | TRUE | -0.2 | -0.09 |
| 2025-05-16 | 3 | 1.2 | CALL | 3 | 54 | 347.82 | TRUE | -0.23 | -0.16 |
| 2025-05-16 | 4 | 0.2 | CALL | 187 | 1569 | 101.17 | TRUE | -0.35 | -0.64 |
| 2025-05-16 | 5 | 0.05 | CALL | 68 | 3738 | 172.91 | FALSE | -0.09 | -0.64 |
| 2025-05-16 | 6 | 0.03 | CALL | 1 | 1489 | 237.27 | FALSE | -0.02 | -0.4 |
| 2025-05-16 | 7 | 0.03 | CALL | 501 | 540 | 304.61 | FALSE | -0.02 | -0.4 |
| 2025-05-16 | 8 | 0.05 | CALL | 0 | 260 | 397.02 | FALSE | 0 | 0 |
| 2025-05-16 | 9 | 0.35 | CALL | 0 | 13 | 546.38 | FALSE | 0 | 0 |
| 2025-05-16 | 10 | 0.15 | CALL | 0 | 204 | 433.9 | FALSE | 0 | 0 |
| 2025-05-16 | 1 | 0.04 | PUT | 0 | 51 | 767.11 | FALSE | 0 | 0 |
| 2025-05-16 | 2 | 0.03 | PUT | 0 | 1984 | 410.21 | FALSE | 0 | 0 |
| 2025-05-16 | 3 | 0.04 | PUT | 53 | 2706 | 226.97 | FALSE | 0 | 0 |
| 2025-05-16 | 4 | 0.15 | PUT | 89 | 624 | 105.25 | FALSE | 0 | 0 |
| 2025-05-16 | 5 | 1 | PUT | 4 | 28 | 179.92 | TRUE | 0.15 | 0.18 |
| 2025-05-16 | 6 | 2.8 | PUT | 0 | 45 | 515.91 | TRUE | 0 | 0 |
| 2025-05-16 | 7 | 2.95 | PUT | 0 | 2 | 456.33 | TRUE | 0 | 0 |
| 2025-05-16 | 8 | 0 | PUT | 0 | 0 | 409.1 | TRUE | 0 | 0 |
| 2025-05-16 | 9 | 0 | PUT | 0 | 0 | 879.81 | TRUE | 0 | 0 |
| 2025-05-16 | 10 | 0 | PUT | 0 | 0 | 503.59 | TRUE | 0 | 0 |
| 2025-06-20 | 1 | 1.85 | CALL | 0 | 27 | 944.55 | TRUE | 0 | 0 |
| 2025-06-20 | 2 | 1.57 | CALL | 0 | 171 | 112.96 | TRUE | 0 | 0 |
| 2025-06-20 | 3 | 1.14 | CALL | 29 | 325 | 100.02 | TRUE | -0.34 | -0.23 |
| 2025-06-20 | 4 | 0.5 | CALL | 102 | 693 | 88.53 | TRUE | -0.24 | -0.32 |
| 2025-06-20 | 5 | 0.22 | CALL | 129 | 630 | 96.73 | FALSE | -0.23 | -0.51 |
| 2025-06-20 | 6 | 0.1 | CALL | 4 | 245 | 102.39 | FALSE | -0.08 | -0.44 |
| 2025-06-20 | 7 | 0.07 | CALL | 2 | 244 | 116.54 | FALSE | -0.03 | -0.3 |
| 2025-06-20 | 8 | 0.25 | CALL | 0 | 26 | 164.73 | FALSE | 0 | 0 |
| 2025-06-20 | 9 | 0.26 | CALL | 0 | 115 | 182.72 | FALSE | 0 | 0 |
| 2025-06-20 | 10 | 0.05 | CALL | 2 | 561 | 156.12 | FALSE | -0.04 | -0.44 |
| 2025-06-20 | 11 | 0.03 | CALL | 1 | 750 | 154.1 | FALSE | 0.03 | 0 |
| 2025-06-20 | 12 | 0.24 | CALL | 0 | 5 | 214.65 | FALSE | 0 | 0 |
| 2025-06-20 | 13 | 0.23 | CALL | 0 | 20 | 225.3 | FALSE | 0 | 0 |
| 2025-06-20 | 14 | 2.7 | CALL | 0 | 0 | 234.96 | FALSE | 0 | 0 |
| 2025-06-20 | 15 | 0.15 | CALL | 0 | 3 | 243.81 | FALSE | 0 | 0 |
| 2025-06-20 | 16 | 2.23 | CALL | 0 | 12 | 251.97 | FALSE | 0 | 0 |
| 2025-06-20 | 17 | 0.1 | CALL | 0 | 34 | 259.53 | FALSE | 0 | 0 |
| 2025-06-20 | 18 | 0.05 | CALL | 0 | 560 | 266.56 | FALSE | 0 | 0 |
| 2025-06-20 | 1 | 0.01 | PUT | 0 | 105 | 246.33 | FALSE | 0 | 0 |
| 2025-06-20 | 2 | 0.22 | PUT | 0 | 160 | 132.01 | FALSE | 0 | 0 |
| 2025-06-20 | 3 | 0.1 | PUT | 55 | 415 | 97.82 | FALSE | -0.02 | -0.17 |
| 2025-06-20 | 4 | 0.46 | PUT | 57 | 282 | 94.78 | FALSE | 0.06 | 0.15 |
| 2025-06-20 | 5 | 0.96 | PUT | 0 | 165 | 92.27 | TRUE | 0 | 0 |
| 2025-06-20 | 6 | 3.45 | PUT | 0 | 2 | 93.87 | TRUE | 0 | 0 |
| 2025-06-20 | 7 | 2.95 | PUT | 0 | 20 | 151.33 | TRUE | 0 | 0 |
| 2025-06-20 | 8 | 4.1 | PUT | 10 | 7 | 173.96 | TRUE | 4.1 | 0 |
| 2025-06-20 | 9 | 5.1 | PUT | 1 | 11 | 193.06 | TRUE | 5.1 | 0 |
| 2025-06-20 | 10 | 4.6 | PUT | 0 | 0 | 136.04 | TRUE | 0 | 0 |
| 2025-06-20 | 11 | 5.1 | PUT | 0 | 1 | 252.73 | TRUE | 0 | 0 |
| 2025-06-20 | 12 | 0 | PUT | 0 | 0 | 159.45 | TRUE | 0 | 0 |
| 2025-06-20 | 13 | 0 | PUT | 0 | 0 | 169.69 | TRUE | 0 | 0 |
| 2025-06-20 | 14 | 10.85 | PUT | 0 | 0 | 179.15 | TRUE | 0 | 0 |
| 2025-06-20 | 15 | 12 | PUT | 0 | 6 | 269.67 | TRUE | 0 | 0 |
| 2025-06-20 | 16 | 0 | PUT | 0 | 0 | 196.21 | TRUE | 0 | 0 |
| 2025-06-20 | 17 | 0 | PUT | 0 | 0 | 203.96 | TRUE | 0 | 0 |
| 2025-06-20 | 18 | 0 | PUT | 0 | 0 | 211.28 | TRUE | 0 | 0 |
| 2025-07-18 | 1 | 0 | CALL | 0 | 0 | 439.29 | TRUE | 0 | 0 |
| 2025-07-18 | 2 | 1.8 | CALL | 0 | 1 | 104.35 | TRUE | 0 | 0 |
| 2025-07-18 | 3 | 1.1 | CALL | 0 | 80 | 104.18 | TRUE | 0 | 0 |
| 2025-07-18 | 4 | 0.9 | CALL | 0 | 115 | 96.3 | TRUE | 0 | 0 |
| 2025-07-18 | 5 | 0.35 | CALL | 33 | 190 | 93.48 | FALSE | -0.25 | -0.42 |
| 2025-07-18 | 6 | 0.2 | CALL | 31 | 149 | 98.15 | FALSE | -0.15 | -0.43 |
| 2025-07-18 | 7 | 0.21 | CALL | 0 | 289 | 108.87 | FALSE | 0 | 0 |
| 2025-07-18 | 8 | 0.1 | CALL | 3 | 72 | 112.57 | FALSE | 0.1 | 0 |
| 2025-07-18 | 9 | 0.06 | CALL | 77 | 3225 | 112.35 | FALSE | -0.04 | -0.4 |
| 2025-07-18 | 10 | 0.15 | CALL | 0 | 99 | 128.71 | FALSE | 0 | 0 |
| 2025-07-18 | 11 | 3.15 | CALL | 0 | 12 | 154.39 | FALSE | 0 | 0 |
| 2025-07-18 | 12 | 2.5 | CALL | 0 | 1 | 163.43 | FALSE | 0 | 0 |
| 2025-07-18 | 13 | 0 | CALL | 0 | 0 | 171.55 | FALSE | 0 | 0 |
| 2025-07-18 | 14 | 0 | CALL | 0 | 0 | 178.94 | FALSE | 0 | 0 |
| 2025-07-18 | 15 | 0.8 | CALL | 0 | 0 | 185.69 | FALSE | 0 | 0 |
| 2025-07-18 | 16 | 0 | CALL | 0 | 0 | 191.92 | FALSE | 0 | 0 |
| 2025-07-18 | 17 | 0.54 | CALL | 0 | 10 | 197.69 | FALSE | 0 | 0 |
| 2025-07-18 | 18 | 0.57 | CALL | 0 | 12 | 203.06 | FALSE | 0 | 0 |
| 2025-07-18 | 1 | 0.05 | PUT | 1 | 255 | 218 | FALSE | 0 | 0 |
| 2025-07-18 | 2 | 0.28 | PUT | 0 | 11 | 117.99 | FALSE | 0 | 0 |
| 2025-07-18 | 3 | 0.21 | PUT | 4 | 50 | 101.59 | FALSE | 0.01 | 0.05 |
| 2025-07-18 | 4 | 0.7 | PUT | 0 | 1031 | 93.99 | FALSE | 0 | 0 |
| 2025-07-18 | 5 | 1.2 | PUT | 0 | 573 | 91.77 | TRUE | 0 | 0 |
| 2025-07-18 | 6 | 2.15 | PUT | 1 | 91 | 105.67 | TRUE | 2.15 | 0 |
| 2025-07-18 | 7 | 2.95 | PUT | 0 | 4 | 101.12 | TRUE | 0 | 0 |
| 2025-07-18 | 8 | 4.8 | PUT | 0 | 272 | 110.41 | TRUE | 0 | 0 |
| 2025-07-18 | 9 | 0 | PUT | 0 | 0 | 139 | TRUE | 0 | 0 |
| 2025-07-18 | 10 | 6 | PUT | 0 | 20 | 151.67 | TRUE | 0 | 0 |
| 2025-07-18 | 11 | 0 | PUT | 0 | 0 | 215.52 | TRUE | 0 | 0 |
| 2025-07-18 | 12 | 0 | PUT | 0 | 0 | 157.04 | TRUE | 0 | 0 |
| 2025-07-18 | 13 | 0 | PUT | 0 | 0 | 277.87 | TRUE | 0 | 0 |
| 2025-07-18 | 14 | 9.4 | PUT | 0 | 0 | 203.88 | TRUE | 0 | 0 |
| 2025-07-18 | 15 | 0 | PUT | 0 | 0 | 181.72 | TRUE | 0 | 0 |
| 2025-07-18 | 16 | 0 | PUT | 0 | 0 | 159.64 | TRUE | 0 | 0 |
| 2025-07-18 | 17 | 0 | PUT | 0 | 0 | 226 | TRUE | 0 | 0 |
| 2025-07-18 | 18 | 0 | PUT | 0 | 0 | 201.53 | TRUE | 0 | 0 |
| 2025-10-17 | 1 | 2.5 | CALL | 0 | 15 | 324.89 | TRUE | 0 | 0 |
| 2025-10-17 | 2 | 2.25 | CALL | 0 | 13 | 108.89 | TRUE | 0 | 0 |
| 2025-10-17 | 3 | 1.95 | CALL | 0 | 133 | 102.28 | TRUE | 0 | 0 |
| 2025-10-17 | 4 | 1.1 | CALL | 10 | 158 | 100.54 | TRUE | -0.18 | -0.14 |
| 2025-10-17 | 5 | 0.8 | CALL | 12 | 319 | 102.3 | FALSE | -0.25 | -0.24 |
| 2025-10-17 | 6 | 0.5 | CALL | 3 | 239 | 94.57 | FALSE | -0.2 | -0.29 |
| 2025-10-17 | 7 | 0.5 | CALL | 0 | 34 | 94.29 | FALSE | 0 | 0 |
| 2025-10-17 | 8 | 0.32 | CALL | 2 | 48 | 102.74 | FALSE | -0.03 | -0.09 |
| 2025-10-17 | 9 | 0.23 | CALL | 500 | 569 | 101.27 | FALSE | 0.23 | 0 |
| 2025-10-17 | 1 | 0 | PUT | 0 | 0 | 182.84 | FALSE | 0 | 0 |
| 2025-10-17 | 2 | 0.2 | PUT | 30 | 40 | 118.44 | FALSE | 0.2 | 0 |
| 2025-10-17 | 3 | 0.45 | PUT | 20 | 17 | 100.04 | FALSE | 0 | 0 |
| 2025-10-17 | 4 | 1 | PUT | 4 | 2 | 102.78 | FALSE | 0.1 | 0.11 |
| 2025-10-17 | 5 | 1.55 | PUT | 1 | 29 | 91.38 | TRUE | -0.15 | -0.09 |
| 2025-10-17 | 6 | 3.1 | PUT | 0 | 5 | 98.78 | TRUE | 0 | 0 |
| 2025-10-17 | 7 | 0 | PUT | 0 | 0 | 99.62 | TRUE | 0 | 0 |
| 2025-10-17 | 8 | 3.88 | PUT | 1 | 3 | 94.4 | TRUE | 3.88 | 0 |
| 2025-10-17 | 9 | 0 | PUT | 0 | 0 | 97.49 | TRUE | 0 | 0 |
Latest CRVS Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:13 PM EST | 45 | $0.9764 |
| Jun 13, 2022 7:19 PM EST | 2 | $0.9763 |
| Jun 13, 2022 7:20 PM EST | 45 | $0.9734 |
| Jun 13, 2022 7:20 PM EST | 90 | $0.9733 |
| Jun 13, 2022 7:20 PM EST | 100 | $0.9702 |
Corvus Pharmaceuticals, Inc (CRVS) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000110465920073458/0001104659-20-073458-index.htm |
| 2018-08-01 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1626971/000000000018023785/0000000000-18-023785-index.htm |
| 2018-08-24 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1626971/000000000018026391/0000000000-18-026391-index.htm |
| 2020-03-12 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1626971/000000000020002243/0000000000-20-002243-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1626971/000008025519002716/0000080255-19-002716-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1626971/000008025520001312/0000080255-20-001312-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1626971/000031506619000997/0000315066-19-000997-index.htm |
| 2018-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924318017912/0000899243-18-017912-index.htm |
| 2018-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924318017913/0000899243-18-017913-index.htm |
| 2018-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924318017914/0000899243-18-017914-index.htm |
| 2018-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924318017915/0000899243-18-017915-index.htm |
| 2018-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924318017916/0000899243-18-017916-index.htm |
| 2018-12-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924318030242/0000899243-18-030242-index.htm |
| 2018-12-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924318030539/0000899243-18-030539-index.htm |
| 2018-12-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924318031054/0000899243-18-031054-index.htm |
| 2018-12-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924318031055/0000899243-18-031055-index.htm |
| 2018-12-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924318031057/0000899243-18-031057-index.htm |
| 2018-12-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924318031058/0000899243-18-031058-index.htm |
| 2018-12-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924318031059/0000899243-18-031059-index.htm |
| 2018-12-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924318031061/0000899243-18-031061-index.htm |
| 2018-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924318031696/0000899243-18-031696-index.htm |
| 2018-12-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924318031810/0000899243-18-031810-index.htm |
| 2018-12-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924318031989/0000899243-18-031989-index.htm |
| 2019-01-30 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924319002186/0000899243-19-002186-index.htm |
| 2019-01-30 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924319002187/0000899243-19-002187-index.htm |
| 2019-01-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924319002190/0000899243-19-002190-index.htm |
| 2019-01-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924319002194/0000899243-19-002194-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924319017182/0000899243-19-017182-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924319017913/0000899243-19-017913-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924319017914/0000899243-19-017914-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924319017917/0000899243-19-017917-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924319017918/0000899243-19-017918-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924319017919/0000899243-19-017919-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924319017924/0000899243-19-017924-index.htm |
| 2019-08-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000089924319021352/0000899243-19-021352-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1626971/000092189519000470/0000921895-19-000470-index.htm |
| 2019-08-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1626971/000092189519002114/0000921895-19-002114-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1626971/000092189520000529/0000921895-20-000529-index.htm |
| 2020-02-18 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1626971/000092189520000584/0000921895-20-000584-index.htm |
| 2019-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000094787119000486/0000947871-19-000486-index.htm |
| 2019-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000094787119000487/0000947871-19-000487-index.htm |
| 2019-07-02 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1626971/000094787119000489/0000947871-19-000489-index.htm |
| 2019-08-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000094787119000571/0000947871-19-000571-index.htm |
| 2019-08-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000094787119000572/0000947871-19-000572-index.htm |
| 2020-04-17 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1626971/000094787120000390/0000947871-20-000390-index.htm |
| 2018-04-27 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1626971/000110465918027395/0001104659-18-027395-index.htm |
| 2018-05-03 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1626971/000110465918030262/0001104659-18-030262-index.htm |
| 2018-08-17 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1626971/000110465918052661/0001104659-18-052661-index.htm |
| 2018-08-17 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1626971/000110465918052664/0001104659-18-052664-index.htm |
| 2019-05-09 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1626971/000110465919028231/0001104659-19-028231-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000110465919062177/0001104659-19-062177-index.htm |
| 2020-03-09 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1626971/000110465920030827/0001104659-20-030827-index.htm |
| 2020-03-17 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1626971/000110465920034837/0001104659-20-034837-index.htm |
| 2020-03-20 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1626971/000110465920036930/0001104659-20-036930-index.htm |
| 2020-03-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000110465920037295/0001104659-20-037295-index.htm |
| 2020-04-30 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1626971/000110465920054482/0001104659-20-054482-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000110465920073458/0001104659-20-073458-index.htm |
| 2020-10-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000110465920112250/0001104659-20-112250-index.htm |
| 2018-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000114420418035629/0001144204-18-035629-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000114420419032055/0001144204-19-032055-index.htm |
| 2018-05-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184318003466/0001171843-18-003466-index.htm |
| 2018-06-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184318004798/0001171843-18-004798-index.htm |
| 2018-06-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184318004870/0001171843-18-004870-index.htm |
| 2018-08-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184318005700/0001171843-18-005700-index.htm |
| 2018-10-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184318006835/0001171843-18-006835-index.htm |
| 2018-10-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184318007090/0001171843-18-007090-index.htm |
| 2018-11-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184318007480/0001171843-18-007480-index.htm |
| 2018-11-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184318007863/0001171843-18-007863-index.htm |
| 2018-12-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184318008443/0001171843-18-008443-index.htm |
| 2019-01-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184319000179/0001171843-19-000179-index.htm |
| 2019-01-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184319000219/0001171843-19-000219-index.htm |
| 2019-01-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184319000555/0001171843-19-000555-index.htm |
| 2019-02-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184319000753/0001171843-19-000753-index.htm |
| 2019-03-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184319001583/0001171843-19-001583-index.htm |
| 2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184319003207/0001171843-19-003207-index.htm |
| 2019-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184319003763/0001171843-19-003763-index.htm |
| 2019-06-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184319004128/0001171843-19-004128-index.htm |
| 2019-08-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184319005090/0001171843-19-005090-index.htm |
| 2019-10-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184319006916/0001171843-19-006916-index.htm |
| 2019-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184319007381/0001171843-19-007381-index.htm |
| 2019-12-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184319008006/0001171843-19-008006-index.htm |
| 2019-12-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184319008140/0001171843-19-008140-index.htm |
| 2020-02-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184320000651/0001171843-20-000651-index.htm |
| 2020-02-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184320000943/0001171843-20-000943-index.htm |
| 2020-03-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184320001518/0001171843-20-001518-index.htm |
| 2020-03-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184320001878/0001171843-20-001878-index.htm |
| 2020-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184320003129/0001171843-20-003129-index.htm |
| 2020-05-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184320004067/0001171843-20-004067-index.htm |
| 2020-06-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184320004286/0001171843-20-004286-index.htm |
| 2020-07-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184320004791/0001171843-20-004791-index.htm |
| 2020-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184320005409/0001171843-20-005409-index.htm |
| 2020-09-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184320006380/0001171843-20-006380-index.htm |
| 2020-09-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184320006411/0001171843-20-006411-index.htm |
| 2020-09-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184320006493/0001171843-20-006493-index.htm |
| 2020-10-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626971/000117184320007397/0001171843-20-007397-index.htm |
| 2019-01-31 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1626971/000119312519023789/0001193125-19-023789-index.htm |
| 2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1626971/000119312519035923/0001193125-19-035923-index.htm |
| 2019-07-29 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1626971/000119312519205471/0001193125-19-205471-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1626971/000119312520033205/0001193125-20-033205-index.htm |
| 2020-07-09 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1626971/000119312520190472/0001193125-20-190472-index.htm |
| 2019-07-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000120919119043285/0001209191-19-043285-index.htm |
| 2020-05-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000120919120027486/0001209191-20-027486-index.htm |
| 2020-07-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000120919120041990/0001209191-20-041990-index.htm |
| 2018-08-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1626971/000155837018006236/0001558370-18-006236-index.htm |
| 2018-11-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1626971/000155837018008268/0001558370-18-008268-index.htm |
| 2019-03-07 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1626971/000155837019001660/0001558370-19-001660-index.htm |
| 2019-04-24 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1626971/000155837019003229/0001558370-19-003229-index.htm |
| 2019-04-24 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1626971/000155837019003232/0001558370-19-003232-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1626971/000155837019004697/0001558370-19-004697-index.htm |
| 2019-08-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1626971/000155837019006824/0001558370-19-006824-index.htm |
| 2019-10-29 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1626971/000155837019009354/0001558370-19-009354-index.htm |
| 2020-03-09 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1626971/000155837020002232/0001558370-20-002232-index.htm |
| 2020-04-15 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1626971/000155837020003917/0001558370-20-003917-index.htm |
| 2020-04-15 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1626971/000155837020003923/0001558370-20-003923-index.htm |
| 2020-04-30 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1626971/000155837020004797/0001558370-20-004797-index.htm |
| 2020-07-30 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1626971/000155837020008756/0001558370-20-008756-index.htm |
| 2020-10-29 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1626971/000155837020012039/0001558370-20-012039-index.htm |
| 2019-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000156761919013152/0001567619-19-013152-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000156761919013222/0001567619-19-013222-index.htm |
| 2019-11-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000156761919021570/0001567619-19-021570-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000156761919023137/0001567619-19-023137-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000156761919023139/0001567619-19-023139-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000156761919023140/0001567619-19-023140-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000156761919023143/0001567619-19-023143-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000156761919023146/0001567619-19-023146-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000156761919023147/0001567619-19-023147-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000156761919023148/0001567619-19-023148-index.htm |
| 2020-03-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000156761920006904/0001567619-20-006904-index.htm |
| 2020-03-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000156761920006905/0001567619-20-006905-index.htm |
| 2020-03-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000156761920006907/0001567619-20-006907-index.htm |
| 2020-03-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000156761920006908/0001567619-20-006908-index.htm |
| 2020-03-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000156761920006909/0001567619-20-006909-index.htm |
| 2020-03-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000156761920006910/0001567619-20-006910-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000156761920012097/0001567619-20-012097-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000156761920012098/0001567619-20-012098-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000156761920012099/0001567619-20-012099-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000156761920012100/0001567619-20-012100-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000156761920012101/0001567619-20-012101-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000156761920012102/0001567619-20-012102-index.htm |
| 2020-09-15 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000156761920016741/0001567619-20-016741-index.htm |
| 2020-09-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626971/000156761920016744/0001567619-20-016744-index.htm |
| 2020-03-19 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1626971/999999999520000598/9999999995-20-000598-index.htm |
Corvus Pharmaceuticals, Inc (CRVS) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Corvus Pharmaceuticals, Inc (CRVS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 498%Institutional Ownership: 6375%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2018-12-20 | RICHARD A MD MILLER | President and CEO | Buy | 5,000.00 | 4.40 | 22,000.00 | 1,103,795.00 | https://www.sec.gov/Archives/edgar/data/1626971/000089924318031696/0000899243-18-031696-index.htm |
| 2018-12-20 | RICHARD A MD MILLER | President and CEO | Buy | 5,000.00 | 4.39 | 21,950.00 | 1,108,795.00 | https://www.sec.gov/Archives/edgar/data/1626971/000089924318031696/0000899243-18-031696-index.htm |
| 2018-12-04 | RICHARD A MD MILLER | President and CEO | Buy | 1,502.00 | 5.95 | 8,936.90 | 1,113,795.00 | https://www.sec.gov/Archives/edgar/data/1626971/000089924318030242/0000899243-18-030242-index.htm |
| 2018-12-06 | RICHARD A MD MILLER | President and CEO | Buy | 5,000.00 | 5.99 | 29,934.00 | 1,118,795.00 | https://www.sec.gov/Archives/edgar/data/1626971/000089924318030539/0000899243-18-030539-index.htm |
| 2018-12-27 | RICHARD A MD MILLER | President and CEO | Buy | 20,000.00 | 3.29 | 65,884.00 | 1,128,795.00 | https://www.sec.gov/Archives/edgar/data/1626971/000089924318031989/0000899243-18-031989-index.htm |
| 2019-06-07 | RICHARD A MD MILLER | President and CEO | Buy | 9,212.00 | 3.37 | 31,018.65 | 1,138,007.00 | https://www.sec.gov/Archives/edgar/data/1626971/000156761919013222/0001567619-19-013222-index.htm |
| 2019-06-11 | RICHARD A MD MILLER | President and CEO | Buy | 6,000.00 | 3.67 | 22,020.00 | 1,144,007.00 | https://www.sec.gov/Archives/edgar/data/1626971/000156761919013222/0001567619-19-013222-index.htm |
| 2019-06-13 | RICHARD A MD MILLER | President and CEO | Buy | 343.00 | 3.52 | 1,207.36 | 1,144,350.00 | https://www.sec.gov/Archives/edgar/data/1626971/000089924319017182/0000899243-19-017182-index.htm |
| 2019-06-14 | RICHARD A MD MILLER | President and CEO | Buy | 11,657.00 | 3.40 | 39,666.44 | 1,156,007.00 | https://www.sec.gov/Archives/edgar/data/1626971/000089924319017182/0000899243-19-017182-index.htm |
| 2019-08-06 | RICHARD A MD MILLER | President and CEO | Buy | 5,000.00 | 3.58 | 17,875.00 | 1,161,007.00 | https://www.sec.gov/Archives/edgar/data/1626971/000089924319021352/0000899243-19-021352-index.htm |
| 2019-08-07 | RICHARD A MD MILLER | President and CEO | Buy | 2,500.00 | 3.54 | 8,850.00 | 1,163,507.00 | https://www.sec.gov/Archives/edgar/data/1626971/000089924319021352/0000899243-19-021352-index.htm |
| 2019-11-12 | RICHARD A MD MILLER | President and CEO | Buy | 272.00 | 2.90 | 788.80 | 1,163,779.00 | https://www.sec.gov/Archives/edgar/data/1626971/000156761919021570/0001567619-19-021570-index.htm |
| 2019-11-13 | RICHARD A MD MILLER | President and CEO | Buy | 14,736.00 | 3.00 | 44,240.42 | 1,178,515.00 | https://www.sec.gov/Archives/edgar/data/1626971/000156761919021570/0001567619-19-021570-index.htm |
| 2020-07-08 | Holdings A/S Novo | 10% Share Holder | Sell | 741,440.00 | 5.37 | 3,985,165.86 | 1,389,498.00 | https://www.sec.gov/Archives/edgar/data/1626971/000120919120041990/0001209191-20-041990-index.htm |
| 2020-07-07 | Holdings A/S Novo | 10% Share Holder | Sell | 796,622.00 | 5.25 | 4,183,380.77 | 2,130,938.00 | https://www.sec.gov/Archives/edgar/data/1626971/000120919120041990/0001209191-20-041990-index.htm |
| 2018-12-21 | LEIV LEA | Chief Financial Officer | Buy | 24,700.00 | 4.15 | 102,408.67 | 24,700.00 | https://www.sec.gov/Archives/edgar/data/1626971/000089924318031810/0000899243-18-031810-index.htm |
| 2019-07-25 | Holdings A/S Novo | 10% Share Holder | Sell | 1,400,000.00 | 4.00 | 5,600,000.00 | 2,927,560.00 | https://www.sec.gov/Archives/edgar/data/1626971/000120919119043285/0001209191-19-043285-index.htm |
| 2019-06-06 | LEIV LEA | Chief Financial Officer | Buy | 15,500.00 | 3.56 | 55,180.00 | 40,200.00 | https://www.sec.gov/Archives/edgar/data/1626971/000156761919013152/0001567619-19-013152-index.htm |
| 2019-07-24 | Holdings A/S Novo | 10% Share Holder | Sell | 53,240.00 | 5.01 | 266,711.10 | 4,327,560.00 | https://www.sec.gov/Archives/edgar/data/1626971/000120919119043285/0001209191-19-043285-index.htm |
| 2019-07-23 | Holdings A/S Novo | 10% Share Holder | Sell | 39,716.00 | 5.32 | 211,134.23 | 4,380,800.00 | https://www.sec.gov/Archives/edgar/data/1626971/000120919119043285/0001209191-19-043285-index.htm |
| 2019-06-07 | LEIV LEA | Chief Financial Officer | Buy | 10,000.00 | 3.38 | 33,800.00 | 50,200.00 | https://www.sec.gov/Archives/edgar/data/1626971/000156761919013152/0001567619-19-013152-index.htm |
| 2019-06-27 | ORBIMED ADVISORS LLC | Director | Buy | 32,923.00 | 3.34 | 109,962.82 | 6,000,507.00 | https://www.sec.gov/Archives/edgar/data/1626971/000094787119000486/0000947871-19-000486-index.htm |
| 2019-06-27 | Peter A. Thompson | Director | Buy | 32,923.00 | 3.34 | 109,962.82 | 6,000,507.00 | https://www.sec.gov/Archives/edgar/data/1626971/000094787119000487/0000947871-19-000487-index.htm |
| 2019-06-28 | ORBIMED ADVISORS LLC | Director | Buy | 565,178.00 | 3.72 | 2,102,462.16 | 6,565,685.00 | https://www.sec.gov/Archives/edgar/data/1626971/000094787119000486/0000947871-19-000486-index.htm |
| 2019-06-28 | Peter A. Thompson | Director | Buy | 565,178.00 | 3.72 | 2,102,462.16 | 6,565,685.00 | https://www.sec.gov/Archives/edgar/data/1626971/000094787119000487/0000947871-19-000487-index.htm |
| 2019-07-01 | ORBIMED ADVISORS LLC | Director | Buy | 59,243.00 | 3.91 | 231,640.13 | 6,624,928.00 | https://www.sec.gov/Archives/edgar/data/1626971/000094787119000486/0000947871-19-000486-index.htm |
| 2019-07-01 | Peter A. Thompson | Director | Buy | 59,243.00 | 3.91 | 231,640.13 | 6,624,928.00 | https://www.sec.gov/Archives/edgar/data/1626971/000094787119000487/0000947871-19-000487-index.htm |
| 2019-08-06 | ORBIMED ADVISORS LLC | Director | Buy | 142,656.00 | 3.51 | 500,722.56 | 6,767,584.00 | https://www.sec.gov/Archives/edgar/data/1626971/000094787119000571/0000947871-19-000571-index.htm |
| 2019-08-06 | Peter A. Thompson | Director | Buy | 142,656.00 | 3.51 | 500,722.56 | 6,767,584.00 | https://www.sec.gov/Archives/edgar/data/1626971/000094787119000572/0000947871-19-000572-index.htm |